-+ 0.00%
-+ 0.00%
-+ 0.00%

VIATRIS - EXPLORING U.S. COMMERCIALIZATION PARTNER FOR RYZUMVI FOR PRESBYOPIA

Reuters·10/16/2026 20:07:18